Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD9668 as Adjunctive Therapy in Type 2 Diabetes Mellitus
NCT02597101Phase 2Completed
- Start
- Nov 2015
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
A Phase 2 trial of alvelestat in type 2 diabetes mellitus (T2DM). Started Nov 2015; status: completed.
02
Drugs
alvelestat
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02597101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597101.